A Chemosensitivity Test for Superficial Bladder Cancer Based on Three-Dimensional Culture of Tumour Spheroids

European Urology

Volumn 51, Issue 4, 2007, Pages 962-970

  Burgués, Juan Pablo ^a   Gómez, Luis ^b   Pontones, José Luis ^b   Vera, César David ^b   Jiménez Cruz, Juan Fernando ^b   Ozonas, Mariano ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Antitumour drug screening assays; Bladder neoplasms; Drug resistance; Intravesical instillations

Indexed keywords

CIPROFLOXACIN; DOXORUBICIN; EPIRUBICIN; MITOMYCIN C; THIOTEPA; TRYPTOPHAN; VERAPAMIL;

ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CHEMOSENSITIVITY; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; SUPERFICIAL CANCER; TUMOR CELL CULTURE; TUMOR SPHEROID;

ANTINEOPLASTIC AGENTS; CIPROFLOXACIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; EPIRUBICIN; HUMANS; MITOMYCIN; SPHEROIDS, CELLULAR; THIOTEPA; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VERAPAMIL;

EID: 33847134755     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.10.034     Document Type: Article

References (29)

1. Kamat A.M., and Lamm D.L. Intravesical therapy for bladder cancer. Urology 55 (2000) 161-168
2. Weaver D.J., Barrett B.A., Ross G., and Adelstein E.H. Transitional explant reduction assay-a new in vitro testing system for intravesical chemotherapy. J Urol 135 (1986) 386-391
3. Antón-Aparicio L.M., Urmeneta J., Borras M., Balaguer R., and Berian J.M. In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder. Actas Urol Esp 9 (1985) 517-522
4. Turkeri L.N., Akdas G., Ozyurek M., and Akdas A. The role of in vitro chemosensitivity tests to predict the clinical efficacy of antineoplastic agents in genito-urinary tumors. Arch Esp Urol 51 (1998) 398-404
5. Gontero P., Sargent J.M., Hopster D.J., et al. Ex vivo chemosensitivity to mitomycin C in bladder cancer and its relationship with P-glycoprotein and apoptotic factors. Anticancer Res 22 (2002) 4073-4080
6. Desoize B., and Jardillier J. Multicellular resistance: a paradigm for clinical resistance?. Crit Rev Oncol Hematol 36 (2000) 193-207
7. Frisch S.M., and Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124 (1994) 619-626
8. Tannock I.F., Lee C.M., Tunggal J.K., Cowan D.S., and Egorin M.J. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 8 (2002) 878-884
9. Kobayashi H., Man S., Graham C.H., Kapitain S.J., Teicher B.A., and Kerbel R.S. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A 90 (1993) 3294-3298
10. Kugler A., Haschemi R., Zoller G., Gross A.J., Kallerhoff M., and Ringert R.H. In vitro investigations of new therapeutic agents on bladder tumor cell lines. Urol Res 25 (1997) 247-250
11. Kamat A.M., DeHaven J.I., and Lamm D.L. Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Urology 54 (1999) 56-61
12. Seay T.M., Peretsman S.J., and Dixon P.S. Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. J Urol 155 (1996) 757-762
13. Ebisuno S., Inagaki T., Kohjimoto Y., and Ohkawa T. The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro. Cancer 80 (1997) 2263-2267
14. Duffy P.M., Hayes M.C., Cooper A., and Smart C.J. Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric model. Br J Urol 77 (1996) 819-823
15. Harris N.M., Duffy P.M., Crook T.J., et al. Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer. BJU Int 90 (2002) 957-964
16. Hashimoto H., Tokumitsu M., Saga Y., Okuyama M., and Yachiku S. Immunohistochemical expression of P-glycoprotein in the rat urinary bladder and the effect of verapamil on intravesical chemotherapy. Int J Urol 8 (2001) 118-123
17. Bjerkvig R., Hoestmark J., Pedersen P., and Laerum O. Tumor spheroids from biopsy specimens. In: Bjerkvig R. (Ed). Spheroid culture in cancer research (1992), CRC Press, Boca Raton 41-56
18. Dollner R., Granzow C., Helmke B.M., Ruess A., Schad A., and Dietz A. The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma. Anticancer Res 24 (2004) 325-331
19. Gupta S. Molecular steps of cell suicide: an insight into immune senescence. J Clin Immunol 20 (2000) 229-239
20. Phillips R.M., and Clayton M.R. Plateau-phase cultures: an experimental model for identifying drugs which are bioactivated within the microenvironment of solid tumours. Br J Cancer 75 (1997) 196-201
21. Huncharek M., and Kupelnick B. The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder: a metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy. Am J Clin Oncol 27 (2004) 522-528
22. Huncharek M., McGarry R., and Kupelnick B. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Anticancer Res 21 (2001) 765-769
23. Naito S., Kotoh S., Omoto T., et al. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group. Cancer Chemother Pharmacol 42 (1998) 367-372
24. Kabeshima Y., Kubota T., Watanabe M., Hasegawa H., Furukawa T., and Kitajima M. Clinical usefulness of chemosensitivity test for advanced colorectal cancer. Anticancer Res 22 (2002) 3033-3037
25. Kubota T., Egawa T., Otani Y., et al. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination. Anticancer Res 23 (2003) 583-587
26. Nakamori M., Iwahashi M., Nakamura M., and Yamaue H. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma. J Surg Oncol 84 (2003) 10-16
27. Taylor C.G., Sargent J.M., Elgie A.W., et al. Chemosensitivity testing predicts survival in ovarian cancer. Eur J Gynaecol Oncol 22 (2001) 278-282
28. Iwadate Y., Fujimoto S., Namba H., and Yamaura A. Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing. Br J Cancer 89 (2003) 1896-1900
29. Burgués Gasión J.P., and Cruz Jiménez J.F. Improving efficacy of intravesical chemotherapy. Eur Urol 50 (2006) 225-234